|
|
||||||||
1 Laboratory of Structural Biology, Graduate School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan
2 Institute for Biomedical Engineering, Consolidated Research Institute for Advanced Science and Medical Care, Waseda University, 513 Wasedatsurumaki-cho, Shinjuku-ku, Tokyo 162-0041, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In bacteria, the RecA protein catalyzes the homologous-pairing and strand-exchange reactions within the HRR pathway (McEntee et al. 1979; Shibata et al. 1979; Cox & Lehman 1981a,b). As expected, in eukaryotes, the Rad51 protein also catalyzes the homologous-pairing and strand-exchange reactions (Sung 1994; Baumann et al. 1996; Maeshima et al. 1996; Gupta et al. 1997). To do so, the Rad51 protein binds to ssDNA produced at DSB sites and forms a helical nucleoprotein filament. The Rad51-ssDNA filament then binds to double-stranded DNA (dsDNA) and forms the ternary complex containing ssDNA, dsDNA and the Rad51 protein. In the ternary complex, a short heteroduplex is formed by the Rad51-mediated homologous pairing. The heteroduplex region is then extended by the subsequent strand-exchange reaction promoted by the Rad51 protein (Sung 1994; Baumann et al. 1996).
Mutations in the Rad51 gene have been identified in several tumors (Kato et al. 2000; Levy-Lahad et al. 2001; Wang et al. 2001; Blasiak et al. 2003; Jakubowska et al. 2003), suggesting that the Rad51-dependent HRR is involved in tumor suppression mechanisms. In addition, the Tyr315 residue of the human Rad51 protein (HsRad51) was found to be constitutively phosphorylated by the BCR/ABL fusion protein, which is derived from the translocation of the c-ABL gene from chromosome 9 to the BCR gene locus on chromosome 22 (Philadelphia chromosome) in leukemia patients (Slupianek et al. 2001). The Tyr315 residue is also phosphorylated by c-Abl in an ATM-dependent manner under ionizing radiation conditions (Chen et al. 1999). Our previous analyses suggested that the Tyr315 residue is located in the monomer–monomer interface of the HsRad51 filament (Conilleau et al. 2004; Takizawa et al. 2004). Therefore, the amino acid residues near position 315 of the HsRad51 protein may also be involved in the monomer–monomer interaction within the HsRad51 filament.
Interestingly, two HsRad51 sequences, HsRad51-K313 and HsRad51-Q313, were deposited in the database (DDBJ accession nos. D14134 and D13804, respectively). The HsRad51-K313 and HsRad51-Q313 proteins have an amino acid difference at position 313, which is located near position 315. The HsRad51-Lys313 residue is highly conserved among the eukaryotic Rad51 proteins. Therefore, the HsRad51-K313 protein may be the conventional HsRad51 protein. On the other hand, the HsRad51-Q313 protein, in which the Lys313 residue is replaced by the Gln residue, is presumed to be an isoform corresponding to a naturally occurring polymorphic variant (Shinohara et al. 1993; Sigurdsson et al. 2001).
In the present study, we purified the HsRad51-K313 and HsRad51-Q313 proteins. We also purified three more HsRad51 mutants, in which the Lys313 residue was replaced by a basic amino acid residue, Arg, an acidic amino acid residue, Glu and a hydrophobic amino acid residue, Met. The biochemical activities of these purified HsRad51 isoforms and mutants were then tested in vitro.
| Results |
|---|
|
|
|---|
We purified the HsRad51-K313 and HsRad51-Q313 proteins by a four-step purification method, including nickel-nitrilotriacetic acid (Ni-NTA) agarose column chromatography, removal of the hexahistidine tag from the HsRad51 portion with thrombin protease, spermidine precipitation and MonoQ column chromatography (Fig. 1A, lanes 2 and 3). We then tested the strand-exchange activities of the HsRad51-K313 and HsRad51-Q313 proteins. The
X174 phage circular ssDNA (5386 bases) and the linearized
X174 dsDNA (5386 base pairs) were used as DNA substrates (Fig. 1B) and the reactions were conducted in the presence of human RPA (2 µM) and Ca2+. The Ca2+ ion reportedly stimulated the strand-exchange activity of the HsRad51 protein by preserving the active HsRad51 filament on DNA, through modulation of its ATPase activity (Bugreev & Mazin 2004).
|
Time course and protein titration experiments revealed that the HsRad51-K313 protein catalyzed strand exchange; however, the amounts of the jm intermediates and the nc products formed by the HsRad51-K313 protein were significantly lower than those formed by the HsRad51-Q313 protein under the same reaction conditions with Ca2+ (Fig. 1C–I). Interestingly, in the reactions with the HsRad51-Q313 protein, the jm intermediates, which migrated more slowly than the jm intermediates formed by the HsRad51-K313 protein, were also detected (Fig. 1C,G). This suggests that the ability to form the heteroduplex by strand exchange is different between the HsRad51-K313 and KsRad51-Q313 proteins. These differences in the jm formation between the HsRad51-K313 and HsRad51-Q313 proteins were not obvious when the reactions were performed under conditions with Ca2+ and 200 mM KCl, which enhanced the strand-exchange activity of the HsRad51 protein (Fig. 2A, B, D, E). However, the HsRad51-Q313 protein still exhibited the enhanced nc product formation, as compared to the HsRad51-K313 protein (Fig. 2A,C,D,F). Thus, the HsRad51-Q313 protein possesses the enhanced strand-exchange activity.
|
|
Next, we compared the ssDNA-binding activities of the HsRad51-Q313 and HsRad51-K313 proteins. As shown in Fig. 4A, the HsRad51-Q313 protein bound to ssDNA as efficiently as the HsRad51-K313 protein in the absence of Ca2+. Interestingly, in the presence of Ca2+ and a high concentration of the protein (4 µM), both the HsRad51-K313 and HsRad51-Q313 proteins formed large aggregates, which stacked in the wells of the agarose gel (Fig. 4B, lanes 4 and 8). This indicated that the Ca2+ ion actually enhances the polymer formation abilities of the HsRad51-K313 and HsRad51-Q313 proteins with ssDNA. Consistent with its ssDNA-binding ability, the HsRad51-Q313 protein hydrolyzed ATP in a ssDNA-dependent manner, like the HsRad51-K313 protein (Fig. 4C).
|
The dsDNA-unwinding abilities of the HsRad51-K313 and HsRad51-Q313 isoforms
To test whether the HsRad51-Q313 protein has better filament-formation ability than the HsRad51-K313 protein, we performed the dsDNA unwinding assay, which is a more sensitive assay to detect the differences in the filament-formation activity of Rad51 on dsDNA (Fig. 5C). Electron microscopic visualization revealed that both the HsRad51-Q313 and HsRad51-K313 proteins formed nucleoprotein filaments on dsDNA (Fig. 5A,B). The Rad51 protein is known to extensively unwind dsDNA in the Rad51-dsDNA filament, in an ATP-dependent manner (Benson et al. 1994). When covalently closed dsDNA was used as substrate, the ATP-dependent dsDNA unwinding by the Rad51 protein resulted in highly negatively supercoiled DNA (form X). The production of form X depends on the Rad51-filament formation, in which the dsDNA is unwound by the cooperative binding of the Rad51 protein (Fig. 5C).
|
Mutational analysis of the HsRad51-313 residue
We designed three HsRad51 mutants, R313, E313 and M313, in which the Lys313 residue was replaced by Arg, Glu and Met, respectively. Arg, a positively charged hydrophilic residue, may not change the hydrophobic and electrostatic environments around the Lys313 residue. Glu, a negatively charged hydrophilic residue, may change the electrostatic environment. Met, a hydrophobic residue, may change the hydrophobic and electrostatic environments. All three HsRad51 mutants were purified by a four-step purification method, as described above (Fig. 1A, lanes 4–6).
We then tested the strand-exchange activities of these HsRad51 mutants in the presence of Ca2+ and found that the HsRad51-E313 mutant exhibited enhanced strand-exchange activity (Fig. 6A, lanes 5–7 and B,C), like the HsRad51-Q313 isoform (Fig. 6A, lanes 11–13 and B,C). In contrast, the strand-exchange activity of the HsRad51-R313 mutant is the same as that of the HsRad51-K313 protein (Fig. 6A, lanes 14–16 and B,C). The HsRad51-M313 mutant exhibited moderately enhanced strand-exchange activity, as compared to the HsRad51-K313 protein (Fig. 6A, lanes 8–10 and B,C). As shown in Fig. 7A,B, the dsDNA-unwinding activities of the HsRad51-Q313, HsRad51-E313 and HsRad51-M313 proteins (lanes 4, 6 and 7) were better than those of the HsRad51-K313 and HsRad51-R313 proteins (lanes 3 and 5). Therefore, these results indicate that a positive charge (Lys and Arg), but not a negative (Glu) or neutral (Gln and Met) charge, at position 313 of the HsRad51 protein reduces the strand-exchange ability, probably due to its diminished filament-formation ability.
|
|
| Discussion |
|---|
|
|
|---|
In the present study, we first compared the strand-exchange activities of the HsRad51-K313 and HsRad51-Q313 proteins under the conditions with Ca2+ and found that the HsRad51-Q313 protein exhibited enhanced strand-exchange activity, as compared to that of the conventional HsRad51-K313 protein, probably through its enhanced filament-formation ability. In agreement with a previous report (Sigurdsson et al. 2001), the difference in the strand-exchange activity between the HsRad51-K313 and HsRad51-Q313 proteins was not observed, when the reactions were conducted under conditions without Ca2+ (with ammonium sulfate and spermidine). Thus, the Ca2+ ion is an essential factor to reveal the difference in the strand-exchange activity between the HsRad51-K313 and HsRad51-Q313 proteins. The Ca2+ ion reportedly keeps the active HsRad51-ATP-ssDNA filament from dissociating into an inactive ADP-bound form, by modulating its ATPase activity (Bugreev & Mazin 2004). Hence, in the presence of Ca2+, it may become possible to evaluate the strand-exchange activity of the active HsRad51-filament species, because the conversion from the active HsRad51 filament into the inactive form is inhibited.
The enhanced homologous-recombination activity, which may be promoted by the HsRad51-Q313 protein, may cause chromosome aberrations, such as translocations and inversions between homologous sequences. Actually, aneuploidy and multiple chromosomal rearrangements were promoted, when the HsRad51 protein was over-expressed in mammalian cells (Richardson et al. 2004). Thus, the proper control of the homologous-recombination activity is important for the maintenance of genome integrity. Furthermore, enhanced HsRad51 expression was observed in human soft tissue sarcoma cells (Hannay et al. 2007) and the BCR/ABL found in leukemia cells augments the HsRad51-dependent recombination frequency in cells (Slupianek et al. 2001). Such enhancement of the HsRad51 activity has the potential to accelerate malignant transformation and to contribute to chemoresistance in tumor cells. The rare HsRad51-Q313 isoform, which has the enhanced strand-exchange activity, may increase the frequency of chromosome aberrations and chemoresistance in tumor cells by inappropriate recombination in human cells.
The Lys313 residue of the HsRad51 protein is located near the Tyr315 residue, which is constitutively phosphorylated by the BCR/ABL tyrosine kinase in leukemia cells (Slupianek et al. 2001). Our previous analyses suggested that the HsRad51-Tyr315 residue is directly involved in the monomer–monomer interface of the HsRad51 filament (Conilleau et al. 2004), implying that the HsRad51-Lys313 residue may also function in the monomer–monomer interactions of filament formation. Thus, we performed a mutational analysis of the HsRad51-Lys313 residue. The HsRad51-R313, HsRad51-E313 and HsRad51-M313 mutants, in which the Lys313 residue was replaced by Arg, Glu and Met, respectively, were prepared. These Arg, Glu and Met residues were selected as representatives of basic, acidic and hydrophobic amino acid residues, respectively. We found that a positive charge (Lys and Arg), but not a negative charge (Glu), at position 313 of the HsRad51 protein reduced the strand-exchange ability, probably due to its reduced filament-formation ability. Thus, the electrostatic environment around the monomer–monomer interface of the HsRad51 filament plays an important role in the regulation of the HsRad51 function.
To understand the function of the HsRad51-Lys313 residue in the monomer–monomer interaction within the HsRad51 filament, we superimposed the HsRad51-ATPase domain structure (Pellegrini et al. 2002) on the MvRadA filament structure (Wu et al. 2004), which has a helical pitch close to that of the putative active Rad51 filament. In this model, however, the HsRad51-Lys313 residue did not directly contact the neighboring HsRad51 protomer (data not shown). Since the HsRad51-Lys313 residue is predicted to be located near the monomer–monomer interface of the HsRad51 filament, a substitution at position 313 may allosterically affect the monomer–monomer interaction within the HsRad51 filament. The other possibility is that the HsRad51-Lys313 residue faces the monomer–monomer interface in an unpredictable manner in the active filament on ssDNA. Further biochemical and structural analyses of the active HsRad51 filament are awaited.
| Experimental procedures |
|---|
|
|
|---|
The pET15b expression vectors, including the HsRad51 genes inserted at the NdeI site, were constructed using a Quik-Change kit (Stratagene, La Jolla, CA). The hexahistidine-tagged HsRad51 proteins were over-expressed in the E. coli strain JM109 (DE3), which also carried an expression vector for the minor tRNAs (Codon(+)RIL, Novagen). The HsRad51 proteins expressed in the E. coli strain were purified by the four-step method, as described previously (Matsuo et al. 2006). In this method, the purified HsRad51 protein did not include a hexahistidine tag. Protein concentrations were determined using the Bradford method (Bradford 1976), with bovine serum albumin (Pierce, Woburn, MA) as the standard protein.
DNAs
The
X174 phage ssDNA and dsDNA used in the DNA-binding, strand-exchange, dsDNA-unwinding assays were purchased from New England Biolabs. All DNA concentrations are expressed in moles of nucleotides.
Assay for strand exchange
The
X174 circular ssDNA (20 µM) was incubated with the HsRad51 protein at 37 °C for 10 min, in 10 µL of 28 mM HEPES buffer (pH 7.5), containing 60 mM NaCl, 0.04 mM EDTA, 0.8 mM 2-mercaptoethanol, 4% glycerol, 1 mM MgCl2, 1 mM DTT, 1 mM ATP, 0.1 mg/mL bovine serum albumin, 2 mM CaCl2, 20 mM creatine phosphate and 75 µg/mL creatine kinase. When the reactions were conducted in the presence of KCl, 200 mM KCl was added in the reaction mixture. After this incubation, 2 µM RPA was added to the reaction mixture, which was incubated at 37 °C for 10 min. The reactions were then initiated by the addition of 20 µM
X174 linear dsDNA and were continued for the indicated times. For the experiments without CaCl2, 100 mM KCl was added to the reaction mixture and 100 mM (NH4)2SO4 was added after the addition of 2 µM RPA. The reactions were then initiated by the addition of 20 µM
X174 linear dsDNA and 4 mM spermidine and were continued for the indicated times. The reactions were stopped by the addition of 0.1% SDS and 1.97 mg/mL proteinase K (Roche Applied Science) and were further incubated at 37 °C for 20 min. After adding sixfold loading dye, the deproteinized reaction products were separated by 1% agarose gel electrophoresis in 1x TAE buffer at 3.3 V/cm for 4 h. The products were visualized by SYBR Gold (Invitrogen) staining.
dsDNA unwinding assay
The HsRad51 protein (4, 6, and 8 µM) was incubated with the supercoiled dsDNA (
X174; 20 µM) in 10 µL standard reaction buffer, containing 28 mM HEPES (pH 7.5), 60 mM NaCl, 0.04 mM EDTA, 0.8 mM 2-mercaptoethanol, 4% glycerol, 1 mM MgCl2, 1 mM DTT, 1 mM ATP and 0.1 mg/mL BSA, at 23 °C for 30 min. After incubation, 10 units of wheat germ topoisomerase I (Promega, Madison, WI) were added and the dsDNA was allowed to relax for 1 h at 23 °C. The reaction was stopped by adding 1 µL of 1% SDS, followed by the immediate addition of 1 µL in 19.7 mg/mL proteinase K (Roche Applied Science, Basel Switzerland). The reaction mixtures were further incubated at 23 °C for 20 min. The reaction mixtures were then separated on a 1% agarose gel with or without 10 µg/mL chloroquine in 1x TAE buffer (40 mM Tris–acetate and 1 mM EDTA) at 3.3 V/cm for 20 h. The bands were visualized by ethidium bromide staining.
ATPase activity
The HsRad51-K313 (5 µM) or HsRad51-Q313 (5 µM) proteins was incubated with 1 mM ATP (Roche Applied Science) in 28 mM HEPES buffer (pH 7.5), containing 60 mM NaCl, 1 mM MgCl2, 4% glycerol, 0.04 mM EDTA, 0.8 mM 2-mercaptoethanol, 1 mM dithiothreitol and 0.1 mg/mL bovine serum albumin, in the presence or absence of ssDNA. In the ssDNA-dependent reaction, the
X174 circular ssDNA (40 µM) was used as the substrate. The reaction was performed at 37 °C. After a 10 min pre-incubation in the absence of ATP, the reaction was initiated by adding 1 mM ATP. At each indicated time, a 20 µL aliquot of the reaction mixture was removed and mixed with 30 µL of 100 mM EDTA, to quench the reaction. The amount of inorganic phosphate released was determined by a colorimetric assay. Briefly, a 500-µL aliquot of a malachite green solution [0.034% (w/v) malachite green oxalate, 1.05% (w/v) hexaammonium heptamolybdate tetrahydrate and 0.1% (w/v) polyvinyl alcohol in 1 M HCl] was mixed with 50 µL of sample solution (i.e. the reaction mixture quenched with EDTA). After 1 min, 50 µL of 34% (w/v) sodium citrate dihydrate was added to stop further color development. The absorbance at 655 nm was measured with a 96-well micro plate reader (Bio-Rad, Hercules, CA). A 1-mg/mL phosphate ion standard solution (Wako Pure Chemicals, Osaka, Japan) was used to prepare the phosphate standards.
Assays for ssDNA binding
The
X174 circular ssDNA (40 µM) was mixed with the HsRad51-K313 or HsRad51-Q313 protein in 10 µL of 24 mM HEPES buffer (pH 7.5), containing 30 mM NaCl, 1 mM MgCl2, 2% glycerol, 0.02 mM EDTA, 0.4 mM 2-mercaptoethanol, 1 mM dithiothreitol, 0.1 mg/mL bovine serum albumin and 1 mM ATP in the presence or absence of 2 mM CaCl2. The reaction mixtures were incubated at 37 °C for 10 min and were then analyzed by 0.8% agarose gel electrophoresis in 1x TAE buffer (40 mM Tris–acetate and 1 mM EDTA) at 3.3 V/cm for 2 h. The bands were visualized by ethidium bromide staining.
Gel filtration
The HsRad51-K313 and HsRad51-Q313 proteins (60 or 170 µg) were analyzed by Superdex 200 HR 10/30 (GE Healthcare Bio-Sciences, Chicago, IL) gel filtration chromatography. The elution buffer contained 20 mM HEPES–NaOH (pH 7.5), 200 mM NaCl, 0.1 mM EDTA, 2 mM 2-mercaptoethanol and 10% glycerol and the flow rate was 0.3 mL/min.
Electron microscopy
The HsRad51-K313 or HsRad51-Q313 protein (1 µM) was mixed with pUC119 form II DNA (1 µM) in 20 mM triethanolamine, 1 mM Mg–acetate and 1 mM ATP
S and was incubated for 10 min at 37 °C. Samples (3 µL) were adsorbed on a carbon grid and stained with 2% uranium acetate. The samples were examined with a JEOL JEM2000FX electron microscope.
| Acknowledgements |
|---|
| Footnotes |
|---|
* Correspondence: E-mail: kurumizaka{at}waseda.jp
| References |
|---|
|
|
|---|
Basile, G., Aker, M. & Mortimer, R.K. (1992) Nucleotide sequence and transcriptional regulation of the yeast recombinational repair gene RAD51. Mol. Cell. Biol. 12, 3235–3246.
Baumann, P., Benson, F.E. & West, S.C. (1996) Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 87, 757–766.[CrossRef][Medline]
Benson, F.E., Stasiak, A. & West, S.C. (1994) Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J. 13, 5764–5771.[Medline]
Blasiak, J., Przybylowska, K., Czechowska, A., Zadrozny, M., Pertynski, T., Rykala, J., Kolacinska, A., Morawiec, Z. & Drzewoski, J. (2003) Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer. Acta Biochim. Pol. 50, 249–253.[Medline]
Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.[CrossRef][Medline]
Bugreev, D.V. & Mazin, A. (2004) Ca2+ activates human homologous recombination protein Rad51 by modulating its ATPase activity. Proc. Natl. Acad. Sci. USA 101, 9988–9993.
Chen, G., Yuan, S.S., Liu, W., Xu, Y., Trujillo, K., Song, B., Cong, F., Goff, S.P., Wu, Y., Arlinghaus, R., Baltimore, D., Gasser, P.J., Park, M.S., Sung, P. & Lee, E.Y. (1999) Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274, 12748–12752.
Conilleau, S., Takizawa, Y., Tachiwana, H., Fleury, F., Kurumizaka, H. & Takahashi, M. (2004) Location of tyrosine 315, a target for phosphorylation by cAbl tyrosine kinase, at the edge of the subunit–subunit interface of the human Rad51 filament. J. Mol. Biol. 339, 797–804.[CrossRef][Medline]
Cox, M.M. & Lehman, I.R. (1981a) recA protein of Escherichia coli promotes branch migration, a kinetically distinct phase of DNA strand exchange. Proc. Natl. Acad. Sci. USA 78, 3433–3437.
Cox, M.M. & Lehman, I.R. (1981b) Directionality and polarity in recA protein-promoted branch migration. Proc. Natl. Acad. Sci. USA 78, 6018–6022.
Gupta, R.C., Bazemore, L.R., Golub, E.I. & Radding, C.M. (1997) Activities of human recombination protein Rad51. Proc. Natl. Acad. Sci. USA 94, 463–468.
Hannay, J.A., Liu, J., Zhu, Q.S., Bolshakov, S.V., Li, L., Pisters, P.W., Lazar, A.J., Yu, D., Pollock, R.E. & Lev, D. (2007) Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol. Cancer Ther. 6, 1650–1660.
Jakubowska, A., Narod, S.A., Goldgar, D.E., Mierzejewski, M., Masoj
, B., Nej, K., Huzarska, J., Byrski, T., Górski, B. & Lubi
ski, J. (2003) Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol. Biomarkers Prev. 12, 457–459.
Kato, M., Yano, K., Matsuo, F., Saito, H., Katagiri, T., Kurumizaka, H., Yoshimoto, M., Kasumi, F., Akiyama, F., Sakamoto, G., Nagawa, H., Nakamura, Y. & Miki, Y. (2000) Identification of Rad51 alteration in patients with bilateral breast cancer. J. Hum. Genet. 45, 133–137.[CrossRef][Medline]
Levy-Lahad, E., Lahad, A., Eisenberg, S., Dagan, E., Paperna, T., Kasinetz, L., Catane, R., Kaufman, B., Beller, U., Renbaum, P. & Gershoni-Baruch, R. (2001) A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc. Natl. Acad. Sci. USA 98, 3232–3236.
Lim, D.-S. & Hasty, P. (1996) A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16, 7133–7143.
Maeshima, K., Morimatsu, K. & Horii, T. (1996) Purification and characterization of XRad51.1 protein, Xenopus RAD51 homologue: recombinant XRad51.1 promotes strand exchange reaction. Genes Cells 1, 1057–1068.[Abstract]
Matsuo, Y., Sakane, I., Takizawa, Y., Takahashi, M. & Kurumizaka, H. (2006) Roles of the human Rad51 L1 and L2 loops in DNA binding. FEBS J. 273, 3148–3159.[CrossRef][Medline]
McEntee, K., Weinstock, G.M. & Lehman, I.R. (1979) Initiation of general recombination catalyzed in vitro by the recA protein of Escherichia coli. Proc. Natl. Acad. Sci. USA 76, 2615–2619.
Morita, T., Yoshimura, Y., Yamamoto, A., Murata, K., Mori, M., Yamamoto, H. & Matsushiro, A. (1993) A mouse homolog of the Escherichia coli recA and Saccharomyces cerevisiae RAD51 genes. Proc. Natl. Acad. Sci. USA. 90, 6577–6580.
Pellegrini, L., Yu, D.S., Lo, T., Anand, S., Lee, M., Blundell, T.L. & Venkitaraman, A.R. (2002) Insights into DNA recombination from the structure of a RAD51–BRCA2 complex. Nature 420, 287–293.[CrossRef][Medline]
Richardson, C., Stark, J.M., Ommundsen, M. & Jasin, M. (2004) Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene 23, 546–553.[CrossRef][Medline]
Shibata, T., DasGupta, C., Cunningham, R.P. & Radding, C.M. (1979) Purified Escherichia coli recA protein catalyzes homologous pairing of superhelical DNA and single-stranded fragments. Proc. Natl. Acad. Sci. USA 76, 1638–1642.
Shinohara, A., Ogawa, H. & Ogawa, T. (1992) Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69, 457–470.[CrossRef][Medline]
Shinohara, A., Ogawa, H., Matsuda, Y., Ushio, N., Ikeo, K. & Ogawa, T. (1993) Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nat. Genet. 4, 239–243.[CrossRef][Medline]
Sigurdsson, S., Trujillo, K., Song, B., Stratton, S. & Sung, P. (2001) Basis for avid homologous DNA strand exchange by human Rad51 and RPA. J. Biol. Chem. 276, 8798–8806.
Slupianek, A., Schmutte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M.O., Pierce, A.J., Fishel, R. & Skorski, T. (2001) BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol. Cell 8, 795–806.[CrossRef][Medline]
Sonoda, E., Sasaki, M.S., Buerstedde, J.-M., Bezzubova, O., Shinohara, A., Ogawa, H., Takata, M., Yamaguchi-Iwai, Y. & Takeda, S. (1998) Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17, 598–608.[CrossRef][Medline]
Sonoda, E., Takata, M., Yamashita, Y.M., Morrison, C. & Takeda, S. (2001) Homologous DNA recombination in vertebrate cells. Proc. Natl. Acad. Sci. USA 98, 8388–8394.
Sung, P. (1994) Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science 265, 1241–1243.
Takizawa, Y., Kinebuchi, T., Kagawa, W., Yokoyama, S., Shibata, T. & Kurumizaka, H. (2004) Mutational analyses of the human Rad51-Tyr315 residue, a site for phosphorylation in leukaemia cells. Genes Cells 9, 781–790.
Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y. & Morita, T. (1996) Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93, 6236–6240.
Wang, W.W., Spurdle, A.B., Kolachana, P., et al. (2001) A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol. Biomarkers Prev. 10, 955–960.
Wu, Y., He, Y., Moya, I.A., Qian, X. & Luo, Y. (2004) Crystal structure of archaeal recombinase RADA: snapshot of its extended comformation. Mol. Cell 15, 423–435.[CrossRef][Medline]
Yoshimura, Y., Morita, T., Yamamoto, A. & Matsushiro, A. (1993) Cloning and sequence of the human RecA-like gene cDNA. Nucleic Acids Res. 21, 1665.
Received: 16 June 2007
Accepted: 23 October 2007
This article has been cited by other articles:
![]() |
Y. Morozumi, Y. Takizawa, M. Takaku, and H. Kurumizaka Human PSF binds to RAD51 and modulates its homologous-pairing and strand-exchange activities Nucleic Acids Res., July 1, 2009; 37(13): 4296 - 4307. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishida, Y. Takizawa, T. Kainuma, J. Inoue, T. Mikawa, T. Shibata, H. Suzuki, S. Tashiro, and H. Kurumizaka DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchange Nucleic Acids Res., June 1, 2009; 37(10): 3367 - 3376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takaku, S. Machida, N. Hosoya, S. Nakayama, Y. Takizawa, I. Sakane, T. Shibata, K. Miyagawa, and H. Kurumizaka Recombination Activator Function of the Novel RAD51- and RAD51B-binding Protein, Human EVL J. Biol. Chem., May 22, 2009; 284(21): 14326 - 14336. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sakane, C. Kamataki, Y. Takizawa, M. Nakashima, S. Toki, H. Ichikawa, S. Ikawa, T. Shibata, and H. Kurumizaka Filament formation and robust strand exchange activities of the rice DMC1A and DMC1B proteins Nucleic Acids Res., August 1, 2008; 36(13): 4266 - 4276. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |